Hsbc Holdings PLC Has $15.57 Million Stock Position in Walgreens Boots Alliance, Inc. $WBA

Key Points

• Hsbc Holdings PLC reduced its stake in Walgreens Boots Alliance by 34.1%, owning 1,395,255 shares after selling 721,053 shares in the first quarter.
• Charle Schwab Investment Management increased its stake in Walgreens Boots Alliance by 10.8%, now holding 14,580,827 shares valued at approximately $162.87 million.
• Walgreens Boots Alliance reported a 7.2% increase in quarterly revenue year-over-year, reaching $38.99 billion, with earnings per share of $0.38 compared to analysts' estimates of $0.34.

Hsbc Holdings PLC decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 34.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 1,395,255 shares of the pharmacy operator's stock after selling 721,053 shares during the period. Hsbc Holdings PLC owned approximately 0.16% of Walgreens Boots Alliance worth $15,572,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Townsquare Capital LLC raised its holdings in Walgreens Boots Alliance by 2.3% in the 1st quarter. Townsquare Capital LLC now owns 44,104 shares of the pharmacy operator's stock valued at $493,000 after acquiring an additional 996 shares during the period. Central Pacific Bank Trust Division raised its holdings in Walgreens Boots Alliance by 28.6% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock valued at $50,000 after acquiring an additional 1,000 shares during the period. Frank Rimerman Advisors LLC raised its holdings in Walgreens Boots Alliance by 6.6% in the 1st quarter. Frank Rimerman Advisors LLC now owns 17,682 shares of the pharmacy operator's stock valued at $198,000 after acquiring an additional 1,094 shares during the period. Independent Advisor Alliance raised its holdings in Walgreens Boots Alliance by 3.0% in the 1st quarter. Independent Advisor Alliance now owns 39,978 shares of the pharmacy operator's stock valued at $447,000 after acquiring an additional 1,150 shares during the period. Finally, Twelve Points Wealth Management LLC raised its holdings in Walgreens Boots Alliance by 4.5% in the 1st quarter. Twelve Points Wealth Management LLC now owns 27,837 shares of the pharmacy operator's stock valued at $311,000 after acquiring an additional 1,199 shares during the period. Institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA remained flat at $11.98 during trading hours on Friday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.32 and a current ratio of 0.60. The firm has a market cap of $10.37 billion, a P/E ratio of -1.64, a price-to-earnings-growth ratio of 1.41 and a beta of 0.80. The company's 50 day simple moving average is $11.68 and its 200-day simple moving average is $11.23. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.04. The business had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The firm's revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter last year, the business posted $0.63 EPS. Analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have weighed in on WBA. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen initiated coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a "hold" rating on the stock. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Two investment analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Reduce" and an average price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.